Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in J Clin Psychiatry

Retrieve available abstracts of 23 articles:
HTML format



Single Articles


    September 2021
  1. ZANG F, Zhu Y, Liu X, Fan D, et al
    Polygenic Effects of the Lipid Metabolic Pathway Accelerated Pathological Changes and Disrupted Default Mode Network Trajectory Across the Alzheimer's Disease Spectrum.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


    June 2021
  2. BURKE AD, Apostolova L
    Treatment Challenges and the Hope of Emerging Therapies in Early-Stage Alzheimer Disease.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


    May 2021
  3. BURKE AD
    Can Emerging Therapies Resolve Unmet Needs With Current Treatment in Early-Stage Alzheimer Disease?
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  4. GOLDFARB D
    Advances in Diagnosis of Alzheimer Disease and Emerging Treatment Targets.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


  5. APOSTOLOVA L
    Early-Stage Alzheimer Primer: Pathophysiology, Diagnosis, and Assessment.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available


    April 2020
  6. AVIDAN A, Burke A
    Identifying and Treating Insomnia in Patients Living With Alzheimer's Disease.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


    February 2020
  7. NAGATA T, Shinagawa S, Yoshida K, Noda Y, et al
    Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


    December 2019
  8. ATRI A, Goldfarb D, Sheard S, Shaughnessy L, et al
    Current and Emerging Solutions to Challenges in the Management of Alzheimer's Disease.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    September 2019
  9. ATRI A, Sheard S, Goldfarb D
    A Multidisciplinary Approach for Addressing Challenges in Alzheimer's Disease.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    June 2019
  10. SHAUGHNESSY L, Sheard S, Goldfarb D, Atri A, et al
    Cognitive Assessment of Alzheimer's Disease and Dementias in Clinical Practice: Pragmatics of Brief Instruments and Neuropsychological Evaluation.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    March 2019
  11. GOLDFARB D, Sheard S, Shaughnessy L, Atri A, et al
    Disclosure of Alzheimer's Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    January 2019
  12. RUTHIRAKUHAN M, Lanctot KL, Vieira D, Herrmann N, et al
    Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-Analysis.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    November 2018
  13. SUGIMOTO T, Ono R, Kimura A, Saji N, et al
    Physical Frailty Correlates With Behavioral and Psychological Symptoms of Dementia and Caregiver Burden in Alzheimer's Disease.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


    April 2018
  14. NIELSEN RE, Valentin JB, Lolk A, Andersen K, et al
    Effects of Antipsychotics on Secular Mortality Trends in Patients With Alzheimer's Disease.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


    February 2018
  15. YE Q, Chen H, Su F, Shu H, et al
    An Inverse U-Shaped Curve of Resting-State Networks in Individuals at High Risk of Alzheimer's Disease.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


    October 2017
  16. OZAWA C, Roberts R, Yoshida K, Suzuki T, et al
    Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD Data.
    J Clin Psychiatry. 2017 Oct 17. pii: 17m11461. doi: 10.4088/JCP.17m11461.
    PubMed     Abstract available


  17. GERRETSEN P, Chung JK, Shah P, Plitman E, et al
    Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    J Clin Psychiatry. 2017 Oct 10. pii: 16m11367. doi: 10.4088/JCP.16m11367.
    PubMed     Abstract available


    July 2017
  18. REEVES S, Bertrand J, McLachlan E, D'Antonio F, et al
    A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease.
    J Clin Psychiatry. 2017;78:e844-e851.
    PubMed     Abstract available


    January 2017
  19. KOPONEN M, Taipale H, Lavikainen P, Tanskanen A, et al
    Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
    J Clin Psychiatry. 2017 Jan 31. doi: 10.4088/JCP.15m10458.
    PubMed     Abstract available


  20. LIPEROTI R, Sganga F, Landi F, Topinkova E, et al
    Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive Impairment.
    J Clin Psychiatry. 2017;78:e76-e82.
    PubMed     Abstract available


    December 2016
  21. CHENG C, Zandi P, Stuart E, Lin CH, et al
    Association Between Lithium Use and Risk of Alzheimer's Disease.
    J Clin Psychiatry. 2016 Dec 20. doi: 10.4088/JCP.15m10304.
    PubMed     Abstract available


  22. WEAMER EA, DeMichele-Sweet MA, Cloonan YK, Lopez OL, et al
    Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.
    J Clin Psychiatry. 2016;77:e1564-e1569.
    PubMed     Abstract available


    October 2016
  23. CAVEDO E, Dubois B, Colliot O, Lista S, et al
    Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease.
    J Clin Psychiatry. 2016 Oct 25. doi: 10.4088/JCP.15m10413.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: